greeksoup/ stock research
Stock research / United States / NVO / Year to 31 December 2025

Novo Nordisk A/S (NVO) annual results, year to 31 December 2025: revenue DKK 309,064 million, from the 20-F

Novo Nordisk A/S files a 20-F with the SEC once a year, in Danish kroner. In the year to 31 December 2025 it reported revenue of DKK 309,064 million ($46.8 billion at the year's average rate), up 6.4% on the year before. Its profit was DKK 102,434 million, up 1.4%, and diluted earnings per share DKK 23.03.

Revenue
DKK 309,064 million
+6.4% on the year
FY2019FY2025
Operating margin
41.3%
44.2% a year earlier
FY2019FY2025
Net income
DKK 102,434 million
+1.4% on the year
FY2019FY2025
Diluted EPS
DKK 23.03
+1.8% on the year
FY2019FY2025

this yearthe year beforeIn Danish kroner as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2024 †Dec 2025
Revenue290,403309,064
Cost of sales44,52258,788
Gross profit245,881250,276
Research and development48,06252,039
Operating profit128,339127,658
Finance costs7,3466,778
Profit before tax127,191130,540
Income tax26,20328,106
Profit for the year100,988102,434
Profit attributable to shareholders100,988102,434
Filing20-F20-F
DKK million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2024 †Dec 2025
Diluted EPS22.6323.03
Basic EPS22.6723.06
Filing20-F20-F

DKK per ordinary share, as filed.

Cash flow

Year toDec 2024 †Dec 2025
Cash from operations120,968119,102
Purchase of property, plant and equipment47,16460,140
Free cash flow73,80458,962
Cash from investing-128,895-79,158
Cash from financing8,735-28,408
Depreciation and amortisation8,54514,666
Buybacks20,1811,388
Dividends paid44,14051,763
Filing20-F20-F

DKK million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2024 †Dec 2025
Funded by
Equity attributable to shareholders143,486194,047
Borrowings, as filed102,787130,958
Lease liabilities6,7668,572
Other liabilities212,591209,325
Total equity and liabilities465,630542,902
Owned
Property, plant and equipment161,680208,378
Goodwill20,01719,845
Other intangible assets90,804110,208
Cash and cash equivalents15,65526,464
Inventories40,84949,623
Other assets136,625128,384
Total assets465,630542,902
Filing20-F20-F

DKK million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2024 †Dec 2025
Gross margin84.7%81.0%
Operating margin44.2%41.3%
Net margin34.8%33.1%
Free cash flow margin25.4%19.1%
Return on year-end equity70.4%52.8%
Effective tax rate20.6%21.5%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2025, filed 4 February 2026: the filing. The figures are in Danish kroner as filed.